These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3157817

  • 1. Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
    Nakata K, Suda H, Yamauchi H, Iso T.
    Jpn J Pharmacol; 1985 Jan; 37(1):83-90. PubMed ID: 3157817
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)].
    Fujimura H, Hiramatsu Y, Tamura Y, Yanagihara M, Koda A, Nagai H, Uda K, Iso T, Yamauchi H.
    Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):117-29. PubMed ID: 6249702
    [Abstract] [Full Text] [Related]

  • 3. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y, Abe T, Edanami K, Agata M, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [Abstract] [Full Text] [Related]

  • 4. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M, Goto K, Maruyama Y.
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [Abstract] [Full Text] [Related]

  • 5. [Effects of ferulic acid on allergic reaction].
    Hu HJ, Hang BQ.
    Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):426-30. PubMed ID: 1840284
    [Abstract] [Full Text] [Related]

  • 6. [Effect of KC-404 on allergic reactions types I-IV].
    Nishino K, Hara S, Irikura T.
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
    Ohmori K, Ishii H, Hirayama T, Shuto K, Nakamizo N.
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
    [Abstract] [Full Text] [Related]

  • 8. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
    Omote M, Sakai K, Mizusawa H.
    Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human gamma-globulin and adjuvant arthritis in rats].
    Yamauchi H, Hayashi M, Kasamatsu S, Suda H, Nakata K, Sasano M, Iso T.
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):275-82. PubMed ID: 2408978
    [Abstract] [Full Text] [Related]

  • 10. [Action of piroxicam on allergic inflammation].
    Abe N, Tanaka K, Kanaoka K, Egawa M, Watanabe I, Hirai S.
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):431-40. PubMed ID: 6629214
    [Abstract] [Full Text] [Related]

  • 11. SA96: an immunopharmacological profile in vitro.
    Yamamoto I, Ohmori H, Okimura T.
    Int J Tissue React; 1982 May; 4(1):1-8. PubMed ID: 7200957
    [Abstract] [Full Text] [Related]

  • 12. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats.
    Hayashi M, Matsunaga K, Okahara A, Mita S.
    J Rheumatol; 1991 May; 18(5):691-5. PubMed ID: 1865415
    [Abstract] [Full Text] [Related]

  • 13. [Effects of MY-5116 on experimental animal models of type I-type IV allergic reactions and the formation of IgE antibody].
    Takahashi K, Endoh K, Yamada N, Kadowaki S, Arai Y, Sugasawa K.
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):245-54. PubMed ID: 2947841
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
    Kamei C, Izushi K, Adachi Y, Shimazawa M, Tasaka K.
    Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of dehydrocorydaline isolated from Corydalis Tuber against type I-IV allergic models.
    Matsuda H, Tokuoka K, Wu J, Shiomoto H, Kubo M.
    Biol Pharm Bull; 1997 Apr; 20(4):431-4. PubMed ID: 9145224
    [Abstract] [Full Text] [Related]

  • 16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Apr; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
    Tomioka K, Yamada T, Mase T, Murase K.
    Pharmacology; 1989 Apr; 39(1):28-38. PubMed ID: 2531424
    [Abstract] [Full Text] [Related]

  • 18. Effects of immunomodulators on candidacidal activity of normal peritoneal cells in BALB/c mice.
    Hayashi M, Abe C, Nozawa RT, Yokota T, Iso T, Shiokawa Y.
    Int J Immunopharmacol; 1986 Apr; 8(3):299-304. PubMed ID: 3733301
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of methanolic extract from corydalis tuber against types I-IV allergic models.
    Matsuda H, Tokuoka K, Wu J, Tanaka T, Kubo M.
    Biol Pharm Bull; 1995 Jul; 18(7):963-7. PubMed ID: 7581251
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A, Nagai H, Sato N, Nakatomi I, Nishiyori T, Mori H, Inagaki N.
    J Pharmacol; 1984 Jul; 15(3):353-73. PubMed ID: 6208430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.